Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleSerum PAI-1 is a novel predictor for response to pegylated interferon-α-2b plus ribavirin therapy in chronic hepatitis C virus infection.AuthorsMiki, D.; Ohishi, W.; Ochi, H.; Hayes, C. N.; Abe, H.; Tsuge, M.; Imamura, M.; Kamatani, N.; Nakamura, Y.; Chayama, K.PublicationJournal of Viral Hepatitis, 2012, Vol 19, Issue 2, pe126ISSN1352-0504Publication typeArticleDOI10.1111/j.1365-2893.2011.01516.x